Literature DB >> 22944539

Prospective evaluation of the use of the thrombolysis in myocardial infarction score as a risk stratification tool for chest pain patients admitted to an ED observation unit.

Jessica Holly1, Matthew Fuller, David Hamilton, Michael Mallin, Kathryn Black, Riann Robbins, Virgil Davis, Troy Madsen.   

Abstract

BACKGROUND: The Thrombolysis in Myocardial Infarction (TIMI) score has shown use in predicting 30-day and 1-year outcomes in emergency department (ED) patients with potential acute coronary syndrome. Few studies have evaluated the TIMI score in risk stratifying patients selected for the ED observation Unit (EDOU). Risk stratification of patients in this group could identify those at risk for significant cardiac events. Our goal was to evaluate TIMI use for risk stratification in this population and compare outcomes among differing scores.
METHODS: A prospective observational study with 30-day telephone follow-up for a 12 month period. Baseline data, outcomes related to EDOU stay, admission, and 30-day outcomes were recorded. TIMI scores were calculated for each patient placed in EDOU. TIMI score was not utilized in the decision to place patients in observation.
RESULTS: N = 552. Composite outcomes recorded were myocardial infarction, revascularization, or death either during the EDOU stay, inpatient admission, or the 30-day follow-up. Eighteen composite outcomes were recorded: stent (12 patients), coronary artery bypass graft (3 patients), myocardial infarction and stent (2 patients), and myocardial infarction, and coronary artery bypass graft (1 patient). Distribution by TIMI score was: 0 (102 patients), 1 (196), 2 (142), 3 (72), 4 (27), and 5 (5). Risk of composite outcome increased by score: 0 (1%), 1 (2.6%), 2 (2.1%), 3 (6.9%), 4 (11.1%), and 5 (20%). Those with an intermediate risk score (3-5) were also more likely to require admission (15.4% vs 9.8%, P = .048).
CONCLUSION: The TIMI risk score may serve as an effective risk stratification tool among chest pain patients selected for EDOU placement. Patients with intermediate-risk by TIMI may be considered for inpatient admission and/or more aggressive evaluation and therapy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22944539     DOI: 10.1016/j.ajem.2012.07.006

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  7 in total

1.  The predictive value of the HEART and GRACE scores for major adverse cardiac events in patients with acute chest pain.

Authors:  Zhenhua Huang; Keke Wang; Daya Yang; Qianlin Gu; Qiuxia Wei; Zhen Yang; Hong Zhan
Journal:  Intern Emerg Med       Date:  2020-05-25       Impact factor: 3.397

2.  Indirect comparison of TIMI, HEART and GRACE for predicting major cardiovascular events in patients admitted to the emergency department with acute chest pain: a systematic review and meta-analysis.

Authors:  Jun Ke; Yiwei Chen; Xiaoping Wang; Zhiyong Wu; Feng Chen
Journal:  BMJ Open       Date:  2021-08-18       Impact factor: 3.006

3.  Discrepancy between clinician and research assistant in TIMI score calculation (TRIAGED CPU).

Authors:  Brian T Taylor; Michelino Mancini
Journal:  West J Emerg Med       Date:  2014-11-11

4.  Comparison of nine coronary risk scores in evaluating patients presenting to hospital with undifferentiated chest pain.

Authors:  Henry Wamala; Leena Aggarwal; Anne Bernard; Ian A Scott
Journal:  Int J Gen Med       Date:  2018-12-13

5.  Development and validation of a risk score for chest pain with suspected non-ST-segment elevation acute coronary syndrome.

Authors:  Chun-Peng Ma; Xiao-Li Liu; Jian-Shuang Feng; Xue-Fei Dong
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-12-29       Impact factor: 1.485

6.  Diagnostic Performance of Coronary Tomography Angiography and Serial Measurements of Sensitive Cardiac Troponin in Patients With Chest Pain and Intermediate Risk for Cardiovascular Events.

Authors:  Alexandre de Matos Soeiro; Bruno Biselli; Tatiana C A T Leal; Aline Siqueira Bossa; Maria Cristina César; Sérgio Jallad; Priscila Gherardi Goldstein; Patrícia Oliveira Guimarães; Carlos Vicente Serrano; Cesar Higa Nomura; Débora Nakamura; Carlos Eduardo Rochitte; Paulo Rogério Soares; Múcio Tavares de Oliveira
Journal:  Arq Bras Cardiol       Date:  2022-05       Impact factor: 2.667

7.  Provocative biomarker stress test: stress-delta N-terminal pro-B type natriuretic peptide.

Authors:  Alexander T Limkakeng; J Clancy Leahy; S Michelle Griffin; Yuliya Lokhnygina; Elias Jaffa; Robert H Christenson; L Kristin Newby
Journal:  Open Heart       Date:  2018-10-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.